查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年細胞生物學市場預測：按產品、技術、應用、最終用戶和地區分類的全球分析
市場調查報告書
商品編碼
1383375

2030 年細胞生物學市場預測：按產品、技術、應用、最終用戶和地區分類的全球分析

Cell Biology Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球細胞生物學市場規模將達206億美元，預計2030年將達到590億美元，預測期內年複合成長率為16.2%。

研究細胞（生命的基本組成部分）的科學領域稱為細胞生物學，有時稱為細胞學。細胞是生物體中發現的最小自主體，人們對其型態、功能和行為進行研究。此外，細胞生物學探索控制細胞如何發育、分裂、溝通以及與外界相互作用的複雜過程。包括新陳代謝、DNA 複製、基因表現、細胞訊號系統等的研究。

據GLOBOCAN稱，癌症病例和癌症死亡人數預計將從2020年的1930萬增加到2040年的近3000萬。

政府資助和支持

細胞生物學研究需要政府的資助和支持，以促進科學發現、醫學進步和生物技術發展。此外，政府也向學術機構、研究中心和生物技術公司提供資金，以支持研究工作、購買尖端設備和聘請科學家。此外，對基本細胞過程的更深入了解、尖端生物技術產品的開發以及細胞生物學發現的加速都可以在此類財政支持下實現。此外，政府的監督和倫理監管也確保了細胞生物學研究的道德性，特別關注倫理、法律和安全標準，最終造福整個社會，從而推動了市場規模的擴大。

高成本和專利問題

細胞生物學研究需要昂貴的設備、試劑和專業知識。此外，進行細胞生物學實驗以及購買必要的設備和消耗品的高昂成本可能會阻礙資源的獲取，特別是對於財力有限的小型研究機構和團體而言。此外，細胞生物學產品和技術的開發和商業化可能會受到智慧財產權和專利糾紛的阻礙。此外，在細胞生物學研究的某些領域，法律複雜性和所有權糾紛可能導致研究延誤和財務損失。因此，這些因素可能會對市場規模產生負面影響。

新的創新工具和技術

由於技術的發展，細胞生物學的研究和應用正在改變。高解析度顯微鏡、單細胞定序和 CRISPR-Cas9 等基因編輯平台徹底改變了我們對細胞功能的理解。此外，借助這些工具，研究人員可以比以往更深入地探討細胞，揭示複雜的分子過程，這些過程正在徹底改變遺傳學、癌症研究、再生醫學和藥物研發發現領域。此外，透過自動化和巨量資料分析簡化實驗和資料處理，可以加快發現的速度。因此，細胞生物學的技術進步有可能擴大知識的邊界並解決健康挑戰，從而推動市場擴張。

標準化和缺乏熟練的專業人員

細胞生物學研究使用複雜的方案和技術，通常會導致變異性和重現性困難。此外，非標準化程序和實驗環境的差異可能會阻礙結果的可靠性和可比性，從而可能對整個領域的進展產生負面影響。此外，細胞生物學某些領域缺乏合格的專家可能會減慢研究和產業成長的速度。

COVID-19 的影響

由於 COVID-19大流行，細胞生物學研究遇到了許多障礙。世界各地的實驗室正在經歷混亂，暫時關閉、進入實驗室受到限制以及研究人員數量減少。此外，它還會導致正在進行的實驗和資料收集的延遲和困難，從而減慢細胞生物學研究的速度。此外，COVID-19 研究比任何其他研究領域消耗更多的時間、金錢和人員，減緩了細胞生物學的進展。合作研究、思想共用和科學進步都受到旅行限制和社交距離政策的限制。因此，細胞生物學研究的正常運作和進展總體上受到了疫情的嚴重阻礙。

分子生物學試劑盒產業預計將在預測期內成為最大的產業

據估計，分子生物學試劑盒領域佔據最大的市場佔有率，因為已經有多種試劑組和儀器可用於分子分析和生物分子的操作。許多分子生物學程序都需要這些工具，包括 DNA 和 RNA 萃取、PCR、基因表現分析和 DNA 定序。這些工具簡化了實驗室操作，使研究人員更容易準確、快速地進行測試。分子生物學試劑盒正在改變這個領域，使分子研究變得更加容易，並促進遺傳、基因組和個人化醫療研究，以了解細胞功能及其如何影響健康和疾病。我們加深了對

基因編輯技術領域預計在預測期內年複合成長率最高

由於其強大的工具和技術可以精確操縱生物體的 DNA，基因編輯技術領域預計將在預測期內實現最高的年複合成長率。此外，常見的技術包括 TALEN、鋅指核酸酶和 CRISPR-Cas9。這些技術可以對基因進行特定修飾，以研究基因功能、治療遺傳異常並創建用於研究和治療目的的基因改造生物體。此外，它還提供了對各種生物過程背後的分子機制的前所未有的見解，為遺傳疾病治療和生物技術應用的進步帶來了巨大希望。因此，這些因素正在顯著推動市場擴張。

比最大的地區

亞太地區在預測期內佔據最大的市場佔有率，這主要是由於醫療保健和研發基礎設施的發展。此外，細胞生物學研究由澳洲國家健康與醫學研究委員會資助，印度生物技術部舉措細胞生物學研究計畫。我們提供協助和支持。此外，這些計畫將增強科學能力，釋放人才，鼓勵尖端細胞生物學技術的發展，最終改善醫療保健，促進經濟成長，推動亞太地區發展，這就是我的目標。

複合年複合成長率最高的地區：

預計北美在預測期內的年複合成長率最高。該地區是尖端研究中心，多所大學、研究機構和生物技術公司為細胞研究和創新制定了標準。此外，該地區對於個人化醫療、幹細胞研究和基因編輯技術的發展至關重要，這些技術正在增進我們對疾病的理解並導致創新治療方法的創造。此外，這個健康的生態系統不僅增強了科學理解，而且顯著促進了全球細胞生物學市場的成長和競爭。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球細胞生物學市場：依產品

  • 顯微鏡和影像處理
    • 電子顯微鏡
    • 螢光顯微鏡
  • 細胞分析設備
  • 分子生物學試劑盒
  • 基於細胞的檢測
  • 其他產品

第6章 全球細胞生物學市場：依技術分類

  • 下一代定序（NGS）
  • 基因編輯技術
  • 生物資訊學和計算工具
  • 細胞培養及組織工程
  • 蛋白質體學和蛋白質分析
  • 其他技術

第7章 全球細胞生物學市場：依應用分類

  • 神經科學
  • 免疫學
  • 幹細胞研究
  • 遺傳學和基因組學
  • 細胞療法和免疫療法
  • 病毒學
  • 其他用途

第8章 全球細胞生物學市場：依最終用戶分類

  • 合約研究組織（CRO）
  • 學術研究所
  • 醫院和醫療保健提供者
  • 臨床實驗室
  • 製藥和生物技術公司
  • 幹細胞和再生醫學公司
  • 其他最終用戶

第9章 全球細胞生物學市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Novartis
  • Pfizer
  • HiMedia Laboratories
  • BD Biosciences
  • Thermo Fisher Scientific
  • GE Healthcare Life Sciences
  • Vertex Pharmaceuticals
  • Qiagen
  • Illumina
  • Bio-Rad Laboratories
  • Lonza Group
  • Amgen
  • Roche
  • Johnson & Johnson
  • PerkinElmer
Product Code: SMRC24225

According to Stratistics MRC, the Global Cell Biology Market is accounted for $20.6 billion in 2023 and is expected to reach $59.0 billion by 2030 growing at a CAGR of 16.2% during the forecast period. The field of science that studies the basic building block of life, the cell, is called cell biology, sometimes referred to as cytology. The smallest autonomous entities found in living beings, cells, are studied in terms of their form, function, and behaviour. Moreover, cell biology explores the complex processes that control cell development, division, communication, and contact with the outside world. It includes research on metabolic, DNA replication, gene expression, and cell signalling systems.

According to GLOBOCAN, cancer cases would increase to almost 30 million by 2040, up from 19.3 million cases and ten million cancer deaths in 2020.

Market Dynamics:

Driver:

Government funding and support

Cell biology research requires government funding and support to advance scientific discovery, medical advancements, and biotechnological developments. Additionally, to support research efforts, buy cutting-edge equipment, and hire scientists, governments provide funding to academic institutions, research centers, and biotech firms. Moreover, a greater comprehension of basic cellular processes, the generation of cutting-edge biotechnological products, and an acceleration of cell biology discoveries are all made possible by this financial support. Furthermore, government monitoring and ethical rules also assist in ensuring that cell biology research is carried out ethically and with the highest care for ethical, legal, and safety standards, eventually benefiting society as a whole, thereby driving the market size.

Restraint:

High expenses and patent issues

Research in cell biology necessitates expensive equipment, reagents, and specialist knowledge. Moreover, access to resources may be hampered by the high expense of conducting cell biology experiments and buying the necessary equipment and supplies, especially for smaller research institutes or groups with little financing. Additionally, the development and commercialization of cell biology products and technology may be hampered by intellectual property rights and patent disputes. Furthermore, certain areas of cell biology research can experience delays and financial losses due to legal complications and ownership disputes. Hence, as a result, these factors may negatively impact market size.

Opportunity:

New Innovative tools and techniques

Cell biology research and applications have changed as a result of technological developments. High-resolution microscopy, single-cell sequencing, and gene editing platforms like CRISPR-Cas9 have all transformed our understanding of how cells function. Additionally, with the support of these tools, researchers can examine cells in unprecedented depth, revealing complex molecular processes that have revolutionized the fields of genetics, cancer research, regenerative medicine, and drug discovery. Furthermore, the speed of discovery has also been accelerated by the streamlining of experiments and data processing enabled by automation and big data analysis. Therefore, technology advancements in cell biology are advancing the boundaries of knowledge and have the potential to solve challenging health issues which thus propel the market expansion.

Threat:

Lack of standardization and skilled professionals

The use of complicated protocols and techniques in cell biology research frequently results in variability and difficulties with reproducibility. Moreover, the dependability and comparability of results can be hampered by unstandardized procedures and differences in experimental circumstances, which can have an adverse effect on the field's overall advancement. Furthermore, the rate of research and growth in the industry, however, may be slowed down by a lack of qualified professionals in certain fields of cell biology.

COVID-19 Impact

Cell biology research has suffered a number of obstacles as a result of the COVID-19 pandemic. Disruptions have affected laboratories all across the world, including temporary closures, access restrictions, and reduced worker numbers. Additionally, this has slowed down cell biology research by causing delays and difficulties in ongoing experiments and data collection. Moreover, COVID-19 research has taken up more time, money, and staff than other fields of study, which has slowed the progress of cell biology. Collaborations, the sharing of ideas and scientific advancements have all been hampered by the restrictions placed by travel restrictions and social distance-reducing policies. Therefore, the normal operation and advancement of cell biology research have generally been significantly hindered by the pandemic.

The Molecular Biology Kits segment is expected to be the largest during the forecast period

The Molecular Biology Kits segment is estimated to hold the largest share, due to a wide range of already prepared reagent kits and instruments intended for molecular analysis and molecular manipulation of biological molecules. These tools are necessary for many molecular biology procedures, including DNA and RNA extraction, PCR, gene expression analysis, and DNA sequencing. They make it easier for researchers to conduct tests accurately and quickly by streamlining and simplifying laboratory operations. By facilitating access to molecular studies and advancing genetic, genomic, and personalized medicine research, molecular biology kits have transformed the discipline and advanced our understanding of cellular functions and how they affect health and illness.

The Gene Editing Technologies segment is expected to have the highest CAGR during the forecast period

The Gene Editing Technologies segment is anticipated to have highest CAGR during the forecast period, due to potent tools and techniques that allow for precise manipulation of an organism's DNA. Additionally, popular methods include TALENs, zinc finger nucleases, and CRISPR-Cas9. In order to study gene function, treat genetic abnormalities, and produce genetically modified creatures for research or therapeutic purposes, these technologies enable specific modifications in genes. Furthermore, it has also provided previously unattainable insights into the molecular mechanisms underlying various biological processes and holds tremendous promise for the treatment of genetic diseases and the advancement of biotechnology applications. Therefore, these factors significantly propel the market expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to infrastructure for healthcare and research and development are the main goals of these efforts. Additionally, Cell biology research is funded by the National Health and Medical Research Council of Australia and Department of Biotechnology in India provides funding and support for cell biology research initiatives. Furthermore, these programs seek to build scientific capacity, draw talent, and encourage the development of cutting-edge cell biology technology, ultimately enhancing healthcare, fostering economic growth, and boosting Asia-Pacific.

Region with highest CAGR:

North America is expected to witness highest CAGR over the projection period. It acts as the center for cutting-edge research, with several universities, research centers, and biotechnology firms setting the standard for cellular research and innovation. Additionally, the area has been essential in the development of personalized medicine, stem cell research, and gene editing technologies, which have advanced our understanding of diseases and led to the creation of innovative therapies. Furthermore, this healthy ecosystem has substantially boosted the growth and competitiveness of the global cell biology market, in addition to advancing scientific understanding.

Key players in the market

Some of the key players in the Cell Biology Market include: Novartis, Pfizer, HiMedia Laboratories, BD Biosciences, Thermo Fisher Scientific, GE Healthcare Life Sciences, Vertex Pharmaceuticals, Qiagen, Illumina, Bio-Rad Laboratories, Lonza Group, Amgen, Roche, Johnson & Johnson and PerkinElmer.

Key Developments:

In September 2023, Ginkgo Bioworks announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug candidates.

In August 2023, Novartis announced that it has completed its acquisition of Chinook Therapeutics, Inc., a Seattle, WA, based Biopharmaceutical Company focused on the discovery, development, and commercialization of precision medicines for kidney diseases.

In July 2023, Novartis' acquisition of biotech company DTx Pharma boosts its neuroscience pipeline and expands its capabilities in RNA-based therapeutics.

Products Covered:

  • Microscopy and Imaging
  • Cell Analysis Instruments
  • Molecular Biology Kits
  • Cell-based Assays
  • Other Products

Technologies Covered:

  • Next-Generation Sequencing (NGS)
  • Gene Editing Technologies
  • Bioinformatics and Computational Tools
  • Cell Culture and Tissue Engineering
  • Proteomics and Protein Analysis
  • Other Technologies

Applications Covered:

  • Neuroscience
  • Immunology
  • Stem Cell Research
  • Genetics and Genomics
  • Cell Therapy and Immunotherapy
  • Virology
  • Other Applications

End Users Covered:

  • Contract Research Organizations (CROs)
  • Academic and Research Institutions
  • Hospitals and Healthcare Providers
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Stem Cell and Regenerative Medicine Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cell Biology Market, By Product

  • 5.1 Introduction
  • 5.2 Microscopy and Imaging
    • 5.2.1 Electron Microscopes
    • 5.2.2 Fluorescence Microscopes
  • 5.3 Cell Analysis Instruments
  • 5.4 Molecular Biology Kits
  • 5.5 Cell-based Assays
  • 5.6 Other Products

6 Global Cell Biology Market, By Technology

  • 6.1 Introduction
  • 6.2 Next-Generation Sequencing (NGS)
  • 6.3 Gene Editing Technologies
  • 6.4 Bioinformatics and Computational Tools
  • 6.5 Cell Culture and Tissue Engineering
  • 6.6 Proteomics and Protein Analysis
  • 6.7 Other Technologies

7 Global Cell Biology Market, By Application

  • 7.1 Introduction
  • 7.2 Neuroscience
  • 7.3 Immunology
  • 7.4 Stem Cell Research
  • 7.5 Genetics and Genomics
  • 7.6 Cell Therapy and Immunotherapy
  • 7.7 Virology
  • 7.8 Other Applications

8 Global Cell Biology Market, By End User

  • 8.1 Introduction
  • 8.2 Contract Research Organizations (CROs)
  • 8.3 Academic and Research Institutions
  • 8.4 Hospitals and Healthcare Providers
  • 8.5 Clinical Laboratories
  • 8.6 Pharmaceutical and Biotechnology Companies
  • 8.7 Stem Cell and Regenerative Medicine Companies
  • 8.8 Other End Users

9 Global Cell Biology Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Novartis
  • 11.2 Pfizer
  • 11.3 HiMedia Laboratories
  • 11.4 BD Biosciences
  • 11.5 Thermo Fisher Scientific
  • 11.6 GE Healthcare Life Sciences
  • 11.7 Vertex Pharmaceuticals
  • 11.8 Qiagen
  • 11.9 Illumina
  • 11.10 Bio-Rad Laboratories
  • 11.11 Lonza Group
  • 11.12 Amgen
  • 11.13 Roche
  • 11.14 Johnson & Johnson
  • 11.15 PerkinElmer

List of Tables

  • Table 1 Global Cell Biology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cell Biology Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Cell Biology Market Outlook, By Microscopy and Imaging (2021-2030) ($MN)
  • Table 4 Global Cell Biology Market Outlook, By Electron Microscopes (2021-2030) ($MN)
  • Table 5 Global Cell Biology Market Outlook, By Fluorescence Microscopes (2021-2030) ($MN)
  • Table 6 Global Cell Biology Market Outlook, By Cell Analysis Instruments (2021-2030) ($MN)
  • Table 7 Global Cell Biology Market Outlook, By Molecular Biology Kits (2021-2030) ($MN)
  • Table 8 Global Cell Biology Market Outlook, By Cell-based Assays (2021-2030) ($MN)
  • Table 9 Global Cell Biology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 10 Global Cell Biology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 11 Global Cell Biology Market Outlook, By Next-Generation Sequencing (NGS) (2021-2030) ($MN)
  • Table 12 Global Cell Biology Market Outlook, By Gene Editing Technologies (2021-2030) ($MN)
  • Table 13 Global Cell Biology Market Outlook, By Bioinformatics and Computational Tools (2021-2030) ($MN)
  • Table 14 Global Cell Biology Market Outlook, By Cell Culture and Tissue Engineering (2021-2030) ($MN)
  • Table 15 Global Cell Biology Market Outlook, By Proteomics and Protein Analysis (2021-2030) ($MN)
  • Table 16 Global Cell Biology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 17 Global Cell Biology Market Outlook, By Application (2021-2030) ($MN)
  • Table 18 Global Cell Biology Market Outlook, By Neuroscience (2021-2030) ($MN)
  • Table 19 Global Cell Biology Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 20 Global Cell Biology Market Outlook, By Stem Cell Research (2021-2030) ($MN)
  • Table 21 Global Cell Biology Market Outlook, By Genetics and Genomics (2021-2030) ($MN)
  • Table 22 Global Cell Biology Market Outlook, By Cell Therapy and Immunotherapy (2021-2030) ($MN)
  • Table 23 Global Cell Biology Market Outlook, By Virology (2021-2030) ($MN)
  • Table 24 Global Cell Biology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 25 Global Cell Biology Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global Cell Biology Market Outlook, By Introduction (2021-2030) ($MN)
  • Table 27 Global Cell Biology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 28 Global Cell Biology Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 29 Global Cell Biology Market Outlook, By Hospitals and Healthcare Providers (2021-2030) ($MN)
  • Table 30 Global Cell Biology Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 31 Global Cell Biology Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 32 Global Cell Biology Market Outlook, By Stem Cell and Regenerative Medicine Companies (2021-2030) ($MN)
  • Table 33 Global Cell Biology Market Outlook, By Other End Users (2021-2030) ($MN)

Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.